Increased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapy

Maryam Darabi1, Mohammed Rabbani, Mohsen Ani

  • 1Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

Hormone replacement therapy (HRT) in post-menopausal women significantly increases leukocyte ATP binding cassette A1 (ABCA1) gene expression. This suggests HRT may offer cardiovascular benefits by enhancing cholesterol efflux pathways.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Cardiovascular Science

Background:

  • ATP binding cassette A1 (ABCA1) is crucial for reverse cholesterol transport, mediating cholesterol efflux to HDL particles.
  • Post-menopausal women often experience altered lipid profiles and cardiovascular risk.
  • Hormone replacement therapy (HRT) is used to manage menopausal symptoms and may impact cardiovascular health.

Purpose of the Study:

  • To investigate the effect of conventional HRT on leukocyte ABCA1 gene expression in post-menopausal women.
  • To assess changes in serum lipids and lipoprotein fractions following HRT.

Main Methods:

  • A cohort of 60 non-obese, normolipidaemic post-menopausal women received oral estrogen and progestin therapy for 3 months.
  • Leukocyte ABCA1 mRNA expression and serum lipid/lipoprotein levels were measured before and after HRT.

Main Results:

  • HRT significantly increased HDL cholesterol and apoA-I levels.
  • HRT significantly decreased apoB and LDL cholesterol levels.
  • Leukocyte ABCA1 gene expression showed a significant increase post-HRT, with an inverse association between ABCA1 expression and changes in TG/HDL cholesterol.

Conclusions:

  • HRT demonstrably increases ABCA1 gene expression in leukocytes.
  • The observed increase in ABCA1 expression may contribute to the beneficial cardiovascular effects of HRT.
  • HRT positively modulates lipid profiles, potentially through enhanced cholesterol efflux mechanisms.
Abstract